Abuse-Resistant and Abuse-Deterrent Formulations and Devices to Avoid the Abuse, Misuse and Diversion of Prescription Opioids by Patients (SBIR)(R43/R44)

Archived

National Institutes of Health

Description

Opioid analgesics are widely prescribed for the treatment of pain patients. The increase in prescription opioids abuse, misuse and diversion warrants the support of new approaches designed to reduce their non-medical use. Among potentially important steps towards the goal of safer opioid analgesics are the efforts to reformulate medication so that an individual would not be able (abuse resistance) or would not want (abuse deterrence) to divert the prescription drug, and to create innovative medication dispensing devices/gadgets. This FOA represents a focused effort of the National Institute on Drug Abuse (NIDA) on preventing diversion and misuse at the patient level.

Who can apply

  • Small businesses

Contact

NIH OER Webmaster <br/>FBOWebmaster@OD.NIH.GOV <br/>
FBOWebmaster@OD.NIH.GOV

Key dates & funding
  • PostedJul 16, 2013
  • ClosesNov 1, 2013
  • Program funding$3,000,000
  • CFDA93.279
Categories

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro